Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn’s Disease to Prevent Loss of Response-Reference-Cited by-同舟云学术

Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn’s Disease to Prevent Loss of Response

Published:2014-12-23 Issue:5 Volume:60 Page:1382-1388
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Kamata Noriko,Oshitani Nobuhide,Watanabe Kenji,Watanabe Kimihiko,Hosomi Shuhei,Noguchi Atsushi,Yukawa Tomomi,Yamagami Hirokazu,Shiba Matsatsugu,Tanigawa Tetsuya,Watanabe Toshio,Tominaga Kazunari,Fujiwara Yasuhiro,Arakawa Tetsuo

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-014-3493-8.pdf

Reference21 articles.

1. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med. 1997;337:1029–1035.

2. Hanauer SB, Fegan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s diseasee: the ACCENT I randomized trial. Lancet. 2002;359:1541–1549.

3. Bhatia JK, Korelitz BI, Panagopoulos G, et al. A prospective open-label trial of Remicade in patients with severe exacerbation of Crohn’s disease requiring hospitalization: a comparison with outcomes previously observed in patients receiving intravenous hydrocortisone. J Clin Gastroenterol. 2007;41:677–681.

4. Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in CD. Inflamm Bowel Dis. 2009;15:1295–1301.

5. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology. 2007;132:52–65.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn’s Disease: New Tools for New Approaches;Nutrients;2024-01-17

2. Partial Enteral Nutrition in Crohn’s Disease;Crohn’s Disease Recent Advances;2021-10-20

3. A random forest model predicts responses to infliximab in Crohn’s disease based on clinical and serological parameters;Scandinavian Journal of Gastroenterology;2021-07-24

4. Contemporary Dietary Therapies in Inflammatory Bowel Disease;Current Treatment Options in Pediatrics;2021-03-14

5. Let Food Be Thy Medicine—Its Role in Crohn’s Disease;Nutrients;2021-03-03